lupus

Amgen
Biotech

Amgen reveals 6-point drop in lupus severity behind ph. 2 win

Amgen has shed light on its phase 2 lupus win, revealing that daxdilimab was tied to a 6-point reduction in disease severity at the lower dose.
James Waldron Sep 30, 2026 4:26am
The sun rising over mountains

Adicet Bio CAR-T sparks lupus remissions in early-stage trial

Sep 28, 2026 6:45am
Make a delay and accumulation of outstanding tasks Full stop

Immunovant ends cutaneous lupus program after phase 2 flop

Sep 23, 2026 8:59am
Honeybee sticking head into honeypot

Beeline flies into ph. 3 as oral lupus drug soars past placebo

Sep 9, 2026 7:00am
Goal disorientation and lack of vision

Alumis crushed by midstage lupus flop but plots path to phase 3

Sep 1, 2026 9:27am
Worker bees in hive seen through honeycomb

Beeline bolsters autoimmune ambitions with $126M

Jun 30, 2026 7:00am